Rheumatology

Nanotechnology therapeutics may improve autoimmune disease treatment by enhancing targeting, lowering toxicity, and enabling immune modulation.

Sjögren’s disease linked to higher cancer risk in patients and close relatives in this cohort study.

Gout biomarkers linked to lipids, amino acids, and genes may help refine future therapeutic targeting. Read more.

Ixekizumab achieved high clinical response rates in children with juvenile idiopathic arthritis in a Phase III trial.

A new transition success score for pediatric rheumatology patients provides a structured method to evaluate outcomes when adolescents move from pediatric to adult care.

Manual acupuncture alleviates rheumatoid arthritis pain by targeting the spinal microglia via NF-κB/STAT3.

Respiratory biologics were prescribed to few eligible adults with asthma and obesity, yet reduced exacerbations significantly.

Large vessel vasculitis may present as leg pain, and FDG-PET/CT uncovered lower extremity predominant disease in 16 patients today.